Literature DB >> 2894886

Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly.

L M Sandler1, J M Burrin, G F Joplin, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2894886      PMCID： PMC2545369          DOI： 10.1136/bmj.296.6624.751-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Long term treatment of acromegaly with a long acting analogue of somatostatin.

Authors:  L J Ch'ng; L M Sandler; M E Kraenzlin; J M Burrin; G F Joplin; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

2.  Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

Authors:  S W Lamberts; P Uitterlinden; L Verschoor; K J van Dongen; E del Pozo
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

3.  The effect of subcutaneous infusion versus subcutaneous injections of a somatostatin analogue (SMS 201-995) on the diurnal GH profile in acromegaly.

Authors:  J Timsit; P Chanson; E Larger; M Duet; A Mosse; P J Guillausseau; A G Harris; M Moulonguet; A Warnet; J Lubetzki
Journal:  Acta Endocrinol (Copenh)       Date:  1987-09

4.  Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995).

Authors:  L M Sandler; J M Burrin; G Williams; G F Joplin; D H Carr; S R Bloom
Journal:  Clin Endocrinol (Oxf)       Date:  1987-01       Impact factor: 3.478
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.